INTERNATIONAL PATENT: TAVOTEK BIOTHERAPEUTICS (HONG KONG) LIMITED FILES APPLICATION FOR "ANTIBODIES TARGETING CD3, CD28 AND PD-L1 AND USES THEREOF"

GENEVA, Oct. 3 -- TAVOTEK BIOTHERAPEUTICS (HONG KONG) LIMITED (Unit 1, 9/F, Wo Hing Commercial Building, 11 Wing Wo Street, CentralHong Kong) filed a patent application (PCT/CN2025/084369) for "ANTIBODIES TARGETING CD3, CD28, AND PD-L1 AND USES THEREOF" on Mar 24, 2025. With publication no. WO/2025/201240, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHOU, Fulai (5F, Building B, No of 999 Yinnan RoadSuzhou, Jiangsu 215124), XU, Yuqiang (5F, Building B, No of 999 Yinnan RoadSuzhou, Jiangsu 215124), JIN, Ying (5F, Buildi...